Grupo Chemo

Insud Pharma, formerly known as Grupo Chemo, is a prominent Spanish multinational pharmaceutical group with a comprehensive presence across the healthcare value chain. The company operates through three core business units: Chemo, which specializes in the development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms; Exeltis, a branded division focused on women's health and dermatology; and mAbxience, a global leader in biosimilar development. With a history spanning over four decades, the group has established a robust global infrastructure including over 15 manufacturing plants and 10 R&D centers. Insud Pharma provides integrated services ranging from chemical synthesis to the commercialization of complex generic and branded medicines. The company is particularly recognized for its leadership in the women's health sector and its significant contributions to the accessibility of biologic therapies through its biosimilar portfolio.